Dubai health Authorities have urged healthcare providers in the Emirate to remain vigilant about the zoonotic disease monkeypox.
23 May 2022, 12:00 AM
31 May 2022, 12:00 AM
In a circular made available on its website, the Dubai Health Authority (DHA) has raised the level of epidemiological surveillance of monkeypox cases in Dubai as a preventive measure.
The circular read, “DHA is raising the level of epidemiological surveillance of Monkeypox cases in Dubai to ensure effective and optimal application of prevention and control measures for potential sources of the infection.”
These measures come as part of DHA’s commitment to control and reduce the spread of communicable diseases that assures protection for people and the community.
According to the Centers for Disease Control and Prevention, Monkeypox is a rare disease caused by infection with the monkeypox virus. Monkeypox virus belongs to the Orthopoxvirus genus in the family Poxviridae.
Monkeypox was first discovered in 1958 when two outbreaks of a pox-like disease occurred in colonies of monkeys kept for research, hence the name ‘ Monkeypox.’ The first human case of Monkeypox was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox.
On May 15, 2022, healthcare providers in the UK notified the World Health Organisation about a cluster of cases of Monkeypox; the index case had recent travel history to Nigeria, according to the annexe issued by DHA.
The advisory by DHA is in line with plans to safeguard public health and in line with preventive measures taken at a national level towards early detection and response to the Monkeypox disease to reduce the risk of its spread.
All health professionals and facilities under DHA jurisdiction have been asked to comply with the circular to avoid legal accountability entirely.